Market Closed -
Sao Paulo
04:07:52 2024-04-26 pm EDT
5-day change
1st Jan Change
14.61
BRL
+4.28%
+4.06%
-19.01%
Sales 2024 *
7.8B
1.52B
Sales 2025 *
8.37B
1.64B
Capitalization
7.96B
1.56B
Net income 2024 *
637M
125M
Net income 2025 *
795M
155M
EV / Sales 2024 *
1.46
x
Net Debt
2024
*
3.44B
672M
Net Debt
2025
*
2.67B
521M
EV / Sales 2025 *
1.27
x P/E ratio 2024 *
12.7
x
P/E ratio 2025 *
10.2
x
Employees
27,300
Yield 2024 *
2.34%
Yield 2025 *
5.32%
Free-Float
43.97%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024
Mar. 08
Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 07
CI
Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 06
CI
Fleury S.A Seeks Inorganic Growth
Nov. 10
CI
Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023
Nov. 10
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 08
CI
Fleury Seeks Inorganic Growth
23-08-04
CI
Transcript : Fleury S.A., Q2 2023 Earnings Call, Aug 04, 2023
23-08-04
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-02
CI
Transcript : Fleury S.A., Q1 2023 Earnings Call, May 05, 2023
23-05-05
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-03
CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.
23-04-27
CI
Transcript : Fleury S.A., Q4 2022 Earnings Call, Mar 17, 2023
23-03-17
Fleury S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
23-03-16
CI
Transcript : Fleury S.A., Q3 2022 Earnings Call, Nov 04, 2022
22-11-04
More news
1 day +4.28%
1 week +4.06%
Current month -2.60%
1 month -2.47%
3 months -11.40%
6 months -5.68%
Current year -19.01%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
00-12-31
Director of Finance/CFO
63
21-07-22
Chief Tech/Sci/R&D Officer
48
06-12-31
Members of the board
Title Age Since
Director/Board Member
72
-
Director/Board Member
78
13-04-08
Director/Board Member
57
21-04-29
More insiders
Date
Price
Change
Volume
24-04-26
14.61
-0.34%
2,941,300
24-04-25
14.66
+0.89%
1,734,000
24-04-24
14.53
-1.29%
3,007,400
24-04-23
14.72
+5.07%
11,137,400
24-04-22
14.01
-0.21%
3,185,300
Delayed Quote
Sao Paulo, April 26, 2024 at 04:07 pm EDT
More quotes
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
More about the company
Last Close Price
14.61
BRL
Average target price
19.9
BRL
Spread / Average Target
+36.21%
Consensus
1st Jan change
Capi.
-19.01% 1.55B -17.89% 8.25B +39.20% 3.57B -39.11% 2.46B -8.06% 2.46B -7.35% 2.38B -12.61% 1.81B -40.66% 1.21B +7.56% 1.11B -15.34% 1.03B
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1